ArticleDrugs in R&D2024

Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2).

Theodore J Kottom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.